CapsoVision, Inc (CV) stock
CVNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30391% above fair value
$6.27+0.00 (0.00%)
Close on Nov 12, 2026Market cap $313.79MP/E –Yield –
CapsoVision ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
CapsoVision's ebitda for the twelve months ending Sep 30, 2026 was -$29.29M. For fiscal 2025 it was -$25.30M.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$25.30M | – |
| FY2024 | Dec 31, 2024 | -$19.71M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$7.33M | – |
| Q2 FY2026 | Jun 30, 2026 | -$7.52M | – |
| Q1 FY2026 | Mar 31, 2026 | -$7.04M | – |
| Q4 FY2025 | Dec 31, 2025 | -$7.41M | – |
| Q3 FY2025 | Sep 30, 2025 | -$7.97M | – |
| Q2 FY2025 | Jun 30, 2025 | -$4.60M | – |
| Q1 FY2025 | Mar 31, 2025 | -$5.33M | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.58M | – |
| Q3 FY2024 | Sep 30, 2024 | -$5.75M | – |
| Q2 FY2024 | Jun 30, 2024 | -$5.22M | – |
See a number that looks wrong?